These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38046733)

  • 21. Epidermal barrier and oxidative stress parameters improve during in 311 nm narrow band UVB phototherapy of plaque type psoriasis.
    Darlenski R; Hristakieva E; Aydin U; Gancheva D; Gancheva T; Zheleva A; Gadjeva V; Fluhr JW
    J Dermatol Sci; 2018 Jul; 91(1):28-34. PubMed ID: 29610017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic AMPK signaling dynamic activation in response to REDOX balance are sentinel biomarkers of exercise and antioxidant intervention to improve blood glucose control.
    Wu M; Zhao A; Yan X; Gao H; Zhang C; Liu X; Luo Q; Xie F; Liu S; Shi D
    Elife; 2022 Sep; 11():. PubMed ID: 36155132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inflammatory marker alteration in response to systemic therapies in psoriasis.
    Grechin C; Gheucă Solovăstru L; Vâță D; Ionela Pătrașcu A; Ioana Grăjdeanu A; Porumb-Andrese E
    Exp Ther Med; 2020 Jul; 20(1):42-46. PubMed ID: 32508991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FORT and FORD: two simple and rapid assays in the evaluation of oxidative stress in patients with type 2 diabetes mellitus.
    Pavlatou MG; Papastamataki M; Apostolakou F; Papassotiriou I; Tentolouris N
    Metabolism; 2009 Nov; 58(11):1657-62. PubMed ID: 19604518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
    Sbidian E; Chaimani A; Garcia-Doval I; Doney L; Dressler C; Hua C; Hughes C; Naldi L; Afach S; Le Cleach L
    Cochrane Database Syst Rev; 2022 May; 5(5):CD011535. PubMed ID: 35603936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating Cell-Free DNA as Inflammatory Marker in Egyptian Psoriasis Patients.
    Anani HAA; Tawfeik AM; Maklad SS; Kamel AM; El-Said EE; Farag AS
    Psoriasis (Auckl); 2020; 10():13-21. PubMed ID: 32607312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of systemic treatment of psoriasis on inflammatory parameters and markers of comorbidities and cardiovascular risk: results of a prospective longitudinal observational study.
    Montaudié H; Albert-Sabonnadière C; Acquacalda E; Fontas E; Danré A; Roux C; Ortonne JP; Lacour JP; Euller-Ziegler L; Passeron T
    J Eur Acad Dermatol Venereol; 2014 Sep; 28(9):1186-91. PubMed ID: 23981008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psoriasis therapy and cardiovascular risk factors: a 12-week follow-up study.
    Coimbra S; Oliveira H; Reis F; Belo L; Rocha S; Quintanilha A; Figueiredo A; Teixeira F; Castro E; Rocha-Pereira P; Santos-Silva A
    Am J Clin Dermatol; 2010 Dec; 11(6):423-32. PubMed ID: 20429617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of total oxidant status, total antioxidant status, and malondialdehyde and catalase levels with psoriasis: a systematic review and meta-analysis.
    Zhang Y; Li Z; Ma Y; Mu Z
    Clin Rheumatol; 2019 Oct; 38(10):2659-2671. PubMed ID: 31321579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The inflammatory response in mild and in severe psoriasis.
    Rocha-Pereira P; Santos-Silva A; Rebelo I; Figueiredo A; Quintanilha A; Teixeira F
    Br J Dermatol; 2004 May; 150(5):917-28. PubMed ID: 15149504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of oxidative stress in patients with sickle cell disease: The glutathione system and the oxidant-antioxidant status.
    Gizi A; Papassotiriou I; Apostolakou F; Lazaropoulou C; Papastamataki M; Kanavaki I; Kalotychou V; Goussetis E; Kattamis A; Rombos I; Kanavakis E
    Blood Cells Mol Dis; 2011 Mar; 46(3):220-5. PubMed ID: 21334230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erythrocyte damage in mild and severe psoriasis.
    Rocha-Pereira P; Santos-Silva A; Rebelo I; Figneiredo A; Quintanilha A; Teixeira F
    Br J Dermatol; 2004 Feb; 150(2):232-44. PubMed ID: 14996093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of inflammatory markers in assessing disease severity and response to treatment in patients with psoriasis treated with etanercept.
    Kanelleas A; Liapi C; Katoulis A; Stavropoulos P; Avgerinou G; Georgala S; Economopoulos T; Stavrianeas NG; Katsambas A
    Clin Exp Dermatol; 2011 Dec; 36(8):845-50. PubMed ID: 21790728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolidase activity in chronic plaque psoriasis patients.
    Sürücü HA; Aksoy N; Ozgöztas O; Sezen H; Yesilova Y; Turan E
    Postepy Dermatol Alergol; 2015 Apr; 32(2):82-7. PubMed ID: 26015776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathophysiological Alterations of Redox Signaling and Endocannabinoid System in Granulocytes and Plasma of Psoriatic Patients.
    Ambrożewicz E; Wójcik P; Wroński A; Łuczaj W; Jastrząb A; Žarković N; Skrzydlewska E
    Cells; 2018 Oct; 7(10):. PubMed ID: 30301214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The serum levels of malondialdehyde, vitamin e and erythrocyte catalase activity in psoriasis patients.
    Pujari VM; Ireddy S; Itagi I; Kumar H S
    J Clin Diagn Res; 2014 Nov; 8(11):CC14-6. PubMed ID: 25584212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methotrexate monotherapy versus methotrexate and apremilast combination therapy in the treatment of palmoplantar psoriasis: A prospective, randomised, assessor-blinded, comparative study.
    Hassanandani T; Panda M; Jena AK; Raj C
    Indian J Dermatol Venereol Leprol; 2023; 89(2):213-220. PubMed ID: 35841363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of oxidant and antioxidant levels in patients with psoriasis.
    Kızılyel O; Akdeniz N; Metin MS; Elmas ÖF
    Turk J Med Sci; 2019 Aug; 49(4):1085-1088. PubMed ID: 31269785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trace elements and oxidative stress status in patients with psoriasis.
    Kirmit A; Kader S; Aksoy M; Bal C; Nural C; Aslan O
    Postepy Dermatol Alergol; 2020 Jun; 37(3):333-339. PubMed ID: 32792872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.